Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-22

Clinical Trial Update: Phage Therapy in Prosthetic Joint Infection Due to Staphylococcus Aureus Treated With DAIR. [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating phage therapy for prosthetic joint infection due to Staphylococcus aureus treated with DAIR (debridement, antibiotics, and implant rete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phagenix phage therapy (bacteriophage therapy)

Snippet

Sponsor: Phagenix | Conditions: Infection of Total Hip Joint Prosthesis, Infection of Total Knee Joint Prosthesis | Phase 2 | Status: UNKNOWN